Carysil Limited Fundamental Analysis
Carysil Limited Fundamental Analysis
Carysil Limited (CARYSIL.NS) shows weak financial fundamentals with a PE ratio of 33.98, profit margin of 10.63%, and ROE of 17.25%. The company generates $9.2B in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 78.5/100 based on profitability, valuation, growth, and balance sheet metrics. The B grade reflects solid fundamentals with room for improvement in valuation or growth.
Fundamental Health Score
We analyze CARYSIL.NS's fundamental strength across five key dimensions:
Efficiency Score
WeakCARYSIL.NS struggles to generate sufficient returns from assets.
Valuation Score
ModerateCARYSIL.NS shows balanced valuation metrics.
Growth Score
ModerateCARYSIL.NS shows steady but slowing expansion.
Financial Health Score
ExcellentCARYSIL.NS maintains a strong and stable balance sheet.
Profitability Score
ModerateCARYSIL.NS maintains healthy but balanced margins.
Key Financial Metrics
Is CARYSIL.NS Expensive or Cheap?
P/E Ratio
CARYSIL.NS trades at 33.98 times earnings. This suggests a premium valuation.
PEG Ratio
When adjusting for growth, CARYSIL.NS's PEG of 0.66 indicates potential undervaluation.
Price to Book
The market values Carysil Limited at 5.49 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.
EV/EBITDA
Enterprise value stands at 17.57 times EBITDA. This signals the market has high growth expectations.
How Well Does CARYSIL.NS Make Money?
Net Profit Margin
For every $100 in sales, Carysil Limited keeps $10.63 as profit after all expenses.
Operating Margin
Core operations generate 14.89 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $17.25 in profit for every $100 of shareholder equity.
ROA
Carysil Limited generates $9.42 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Carysil Limited generates limited operating cash flow of $713.11M, signaling weaker underlying cash strength.
Free Cash Flow
Carysil Limited produces free cash flow of $376.49M, offering steady but limited capital for shareholder returns and expansion.
FCF Per Share
Each share generates $13.24 in free cash annually.
FCF Yield
CARYSIL.NS converts 1.13% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
33.98
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.66
vs 25 benchmark
P/B Ratio
Price to book value ratio
5.49
vs 25 benchmark
P/S Ratio
Price to sales ratio
3.61
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.46
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.44
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.17
vs 25 benchmark
ROA
Return on assets percentage
0.09
vs 25 benchmark
ROCE
Return on capital employed
0.20
vs 25 benchmark
How CARYSIL.NS Stacks Against Its Sector Peers
| Metric | CARYSIL.NS Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 33.98 | 25.55 | Worse (Expensive) |
| ROE | 17.25% | 879.00% | Weak |
| Net Margin | 10.63% | -2722.00% (disorted) | Strong |
| Debt/Equity | 0.46 | 0.61 | Strong (Low Leverage) |
| Current Ratio | 1.44 | 2.43 | Neutral |
| ROA | 9.42% | 290.00% | Weak |
CARYSIL.NS outperforms its industry in 2 out of 6 key metrics, particularly excelling in Net Margin, but lagging in P/E Ratio.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Carysil Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Cyclical, Growth, Discretionary
EPS CAGR
N/A
Industry Style: Cyclical, Growth, Discretionary
FCF CAGR
N/A
Industry Style: Cyclical, Growth, Discretionary